BAX and acute kidney injury: Immunoblot analysis confirmed that EED226 treatment effectively inhibited cisplatin‐induced cleavage of caspase‐3 and expression of Bax, a protein associated with mitochondrial dysfunction and AKI (Figure 2C–E).